...
nvro-img

Nevro Corp, Common Stock

NVRO

NYQ

$3.79

+$0.2

(5.57%)

1D
Industry: Health Care Equipment & Supplies Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$134.52M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
732.11K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.93
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$3.52 L
$22.52 H
$3.79

About Nevro Corp, Common Stock

Nevro Corp., a medical device company, engages in the provision of products for patients suffering from chronic pain in the United States and internationally. The company provides HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS implantable pulse generator (IPG) system, an evidence-based neuromodulation system for the treatment of chronic back and leg pain through paresthesia-free 10 kHz therapy, as well as offers Senza II and Senza Omnia SCS IPG systems. It also offers Senza HFX iQ platform, that includes HFX iQ implantable pulse generator, HFX trial stimulator, and HFX iQ patient remote, as well as HFX App, a patient remote control and the wireless trialing system; and provides sacroiliac joint fusion devices under NevroV1, NevroFix, and NevroPro brands. In addition, the company offers surpass surgical and percutaneous leads. It sells its products through its direct sales force, and a network of sales agents and independent distributors. The company was incorporated in 2006 and is headquartered in Redwood City, California. more

Industry: Health Care Equipment & SuppliesSector: Health Care

Returns

Time FrameNVROSectorS&P500
1-Week Return-6.88%-2.12%-3%
1-Month Return-10.4%-3.42%-0.73%
3-Month Return-35.21%-11.13%2.87%
6-Month Return-55.88%-5.74%7.17%
1-Year Return-82%3.97%25.31%
3-Year Return-95.41%1.05%28.38%
5-Year Return-96.68%34.37%81.89%
10-Year Return-90.37%97.88%183.27%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue390.25M362.05M386.90M406.37M425.17M[{"date":"2019-12-31","value":91.79,"profit":true},{"date":"2020-12-31","value":85.15,"profit":true},{"date":"2021-12-31","value":91,"profit":true},{"date":"2022-12-31","value":95.58,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Cost of Revenue121.91M112.15M120.86M130.00M135.11M[{"date":"2019-12-31","value":90.22,"profit":true},{"date":"2020-12-31","value":83,"profit":true},{"date":"2021-12-31","value":89.45,"profit":true},{"date":"2022-12-31","value":96.21,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Profit268.35M249.90M266.04M276.37M290.06M[{"date":"2019-12-31","value":92.52,"profit":true},{"date":"2020-12-31","value":86.16,"profit":true},{"date":"2021-12-31","value":91.72,"profit":true},{"date":"2022-12-31","value":95.28,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Margin68.76%69.02%68.76%68.01%68.22%[{"date":"2019-12-31","value":99.62,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":99.62,"profit":true},{"date":"2022-12-31","value":98.53,"profit":true},{"date":"2023-12-31","value":98.84,"profit":true}]
Operating Expenses364.83M312.75M356.98M375.20M389.37M[{"date":"2019-12-31","value":93.7,"profit":true},{"date":"2020-12-31","value":80.32,"profit":true},{"date":"2021-12-31","value":91.68,"profit":true},{"date":"2022-12-31","value":96.36,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income(96.48M)(62.85M)(90.93M)(98.84M)(99.31M)[{"date":"2019-12-31","value":-9647900000,"profit":false},{"date":"2020-12-31","value":-6285200000,"profit":false},{"date":"2021-12-31","value":-9093400000,"profit":false},{"date":"2022-12-31","value":-9883600000,"profit":false},{"date":"2023-12-31","value":-9930800000,"profit":false}]
Total Non-Operating Income/Expense(10.52M)(38.20M)(38.97M)(4.31M)7.67M[{"date":"2019-12-31","value":-137.06,"profit":false},{"date":"2020-12-31","value":-497.65,"profit":false},{"date":"2021-12-31","value":-507.75,"profit":false},{"date":"2022-12-31","value":-56.17,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Pre-Tax Income(102.09M)(82.20M)(130.83M)4.26M(97.86M)[{"date":"2019-12-31","value":-2394.16,"profit":false},{"date":"2020-12-31","value":-1927.7,"profit":false},{"date":"2021-12-31","value":-3068.15,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-2295,"profit":false}]
Income Taxes1.60M868.00K534.00K1.26M(5.65M)[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":54.28,"profit":true},{"date":"2021-12-31","value":33.4,"profit":true},{"date":"2022-12-31","value":78.99,"profit":true},{"date":"2023-12-31","value":-353.1,"profit":false}]
Income After Taxes(103.69M)(83.06M)(131.36M)3.00M(92.21M)[{"date":"2019-12-31","value":-3455.05,"profit":false},{"date":"2020-12-31","value":-2767.91,"profit":false},{"date":"2021-12-31","value":-4377.21,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-3072.74,"profit":false}]
Income From Continuous Operations(103.69M)(83.06M)(131.36M)3.00M(102.42M)[{"date":"2019-12-31","value":-3455.05,"profit":false},{"date":"2020-12-31","value":-2767.91,"profit":false},{"date":"2021-12-31","value":-4377.21,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-3413,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(103.69M)(83.06M)(131.36M)3.00M(92.21M)[{"date":"2019-12-31","value":-3455.05,"profit":false},{"date":"2020-12-31","value":-2767.91,"profit":false},{"date":"2021-12-31","value":-4377.21,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-3072.74,"profit":false}]
EPS (Diluted)(3.38)(2.49)(3.19)(0.01)(2.57)[{"date":"2019-12-31","value":-338,"profit":false},{"date":"2020-12-31","value":-249,"profit":false},{"date":"2021-12-31","value":-319,"profit":false},{"date":"2022-12-31","value":-1,"profit":false},{"date":"2023-12-31","value":-257,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

NVRO
Cash Ratio 2.90
Current Ratio 5.02
Quick Ratio 3.76

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

NVRO
ROA (LTM) -9.02%
ROE (LTM) -24.78%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

NVRO
Debt Ratio Lower is generally better. Negative is bad. 0.54
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.46

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

NVRO
Trailing PE NM
Forward PE NM
P/S (TTM) 0.32
P/B 0.49
Price/FCF 836
EV/R 0.25
EV/Ebitda NM
PEG NM

FAQs

What is Nevro Corp share price today?

Nevro Corp (NVRO) share price today is $3.79

Can Indians buy Nevro Corp shares?

Yes, Indians can buy shares of Nevro Corp (NVRO) on Vested. To buy Nevro Corp from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in NVRO stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Nevro Corp be purchased?

Yes, you can purchase fractional shares of Nevro Corp (NVRO) via the Vested app. You can start investing in Nevro Corp (NVRO) with a minimum investment of $1.

How to invest in Nevro Corp shares from India?

You can invest in shares of Nevro Corp (NVRO) via Vested in three simple steps:

  • Click on Sign Up or Invest in NVRO stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Nevro Corp shares
What is Nevro Corp 52-week high and low stock price?

The 52-week high price of Nevro Corp (NVRO) is $22.52. The 52-week low price of Nevro Corp (NVRO) is $3.52.

What is Nevro Corp price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Nevro Corp (NVRO) is

What is Nevro Corp price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Nevro Corp (NVRO) is 0.49

What is Nevro Corp dividend yield?

The dividend yield of Nevro Corp (NVRO) is 0.00%

What is the Market Cap of Nevro Corp?

The market capitalization of Nevro Corp (NVRO) is $134.52M

What is Nevro Corp’s stock symbol?

The stock symbol (or ticker) of Nevro Corp is NVRO

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top